- Home
- EVO vs CMBT Comparison
EVO vs CMBT Comparison
Compare EVO & CMBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVO
- CMBT
- Stock Information
- Founded
- EVO 1993
- CMBT 1989
- Country
- EVO Germany
- CMBT Belgium
- Employees
- EVO N/A
- CMBT N/A
- Industry
- EVO Biotechnology: Pharmaceutical Preparations
- CMBT
- Sector
- EVO Health Care
- CMBT
- Exchange
- EVO Nasdaq
- CMBT NYSE
- Market Cap
- EVO 1.5B
- CMBT 1.7B
- IPO Year
- EVO 2021
- CMBT N/A
- Fundamental
- Price
- EVO $4.34
- CMBT $9.39
- Analyst Decision
- EVO Buy
- CMBT
- Analyst Count
- EVO 2
- CMBT 0
- Target Price
- EVO $5.90
- CMBT N/A
- AVG Volume (30 Days)
- EVO 120.0K
- CMBT 89.9K
- Earning Date
- EVO 08-13-2025
- CMBT 08-07-2025
- Dividend Yield
- EVO N/A
- CMBT 11.17%
- EPS Growth
- EVO N/A
- CMBT N/A
- EPS
- EVO N/A
- CMBT 2.16
- Revenue
- EVO $851,944,444.00
- CMBT $934,913,000.00
- Revenue This Year
- EVO $10.08
- CMBT $5.05
- Revenue Next Year
- EVO $10.99
- CMBT $24.22
- P/E Ratio
- EVO N/A
- CMBT $4.39
- Revenue Growth
- EVO 1.50
- CMBT N/A
- 52 Week Low
- EVO $2.84
- CMBT $7.65
- 52 Week High
- EVO $5.64
- CMBT $18.43
- Technical
- Relative Strength Index (RSI)
- EVO 57.99
- CMBT 52.22
- Support Level
- EVO $4.15
- CMBT $9.15
- Resistance Level
- EVO $4.33
- CMBT $9.75
- Average True Range (ATR)
- EVO 0.11
- CMBT 0.23
- MACD
- EVO 0.02
- CMBT -0.04
- Stochastic Oscillator
- EVO 85.92
- CMBT 52.00
About EVO Evotec SE
Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.
About CMBT EURONAV
CMB.Tech NV owns and operates a fleet of vessels for international maritime shipping and storage of crude oil and petroleum products. It generate a large parts of their revenue from voyage charters, including vessels in pools that predominantly perform voyage charters. The company organizes itself into three divisons: the Marine division, the H2 Infra division and the H2 Industry division. The Marine Division derives maximum revenue.